These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 22898056

  • 41. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
    Genega EM, Ghebremichael M, Najarian R, Fu Y, Wang Y, Argani P, Grisanzio C, Signoretti S.
    Am J Clin Pathol; 2010 Dec; 134(6):873-9. PubMed ID: 21088149
    [Abstract] [Full Text] [Related]

  • 42. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR, Exner M, Haitel A, Krieger S, Thomson RB, Aronson PS, Susani M.
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [Abstract] [Full Text] [Related]

  • 43. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features.
    Mantoan Padilha M, Billis A, Allende D, Zhou M, Magi-Galluzzi C.
    Histopathology; 2013 May; 62(6):941-53. PubMed ID: 23551615
    [Abstract] [Full Text] [Related]

  • 44. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
    Petersson F, Grossmann P, Hora M, Sperga M, Montiel DP, Martinek P, Gutierrez ME, Bulimbasic S, Michal M, Branzovsky J, Hes O.
    Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
    [Abstract] [Full Text] [Related]

  • 45. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
    Zhou J, Yang X, Zhou L, Zhang P, Wang C.
    Dis Markers; 2019 Jul; 2019():4708154. PubMed ID: 31737127
    [Abstract] [Full Text] [Related]

  • 46. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
    Büscheck F, Fraune C, Simon R, Kluth M, Hube-Magg C, Möller-Koop C, Shadanpour N, Bannenberg C, Eichelberg C, Höflmayer D, Clauditz T, Wittmer C, Wilczak W, Sauter G, Fisch M, Rink M, Eichenauer T.
    Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
    [Abstract] [Full Text] [Related]

  • 47. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W, Wang K, Yu W, Liu Y, Chu J, Jiang Y, Li Y.
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [Abstract] [Full Text] [Related]

  • 48. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E, Li M.
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN.
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [Abstract] [Full Text] [Related]

  • 51. Clinicopathological, genetic, ultrastructural characterizations and prognostic factors of papillary renal cell carcinoma: new diagnostic and prognostic information.
    Yu W, Zhang W, Jiang Y, Wang Y, Li Y, Wang J, Sun L, Ran W, Li H.
    Acta Histochem; 2013 Jun; 115(5):452-9. PubMed ID: 23219441
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
    Papworth K, Sandlund J, Grankvist K, Ljungberg B, Rasmuson T.
    Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
    [Abstract] [Full Text] [Related]

  • 54. A case of oncocytic papillary renal cell carcinoma.
    Okada A, Sasaki S, Fujiyoshi Y, Niimi K, Kurokawa S, Umemoto Y, Kohri K.
    Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
    [Abstract] [Full Text] [Related]

  • 55. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma.
    Tretiakova MS, Sahoo S, Takahashi M, Turkyilmaz M, Vogelzang NJ, Lin F, Krausz T, Teh BT, Yang XJ.
    Am J Surg Pathol; 2004 Jan; 28(1):69-76. PubMed ID: 14707866
    [Abstract] [Full Text] [Related]

  • 56. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W, Yu WJ, Jiang YX, Li YJ, Han F, Liu Y, Han ZL.
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [Abstract] [Full Text] [Related]

  • 57. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
    Liu YJ, Ussakli C, Antic T, Liu Y, Wu Y, True L, Tretiakova MS.
    Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
    [Abstract] [Full Text] [Related]

  • 58. Renal cell carcinoma with clear cell and papillary features.
    Ross H, Martignoni G, Argani P.
    Arch Pathol Lab Med; 2012 Apr; 136(4):391-9. PubMed ID: 22458901
    [Abstract] [Full Text] [Related]

  • 59. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
    An J, Park CK, Kim M, Joo JW, Cho NH.
    Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
    [Abstract] [Full Text] [Related]

  • 60. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H, Chen L, Cheng L, Vaziri S, He H, Ganapathi R, Delahunt B, Magi-Galluzzi C, Zhou M.
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.